Back to Search
KENNETH SCHIFFMAN, M.D.
M.D.
Orthopaedic Hand Surgery Physician
NPI: 1760574214Individual
Specialties, Licenses & Credentials
Orthopaedic Hand Surgery PhysicianPrimary
Orthopaedic Surgery — Hand Surgery
Code: 207XS0106X
036065978(IL)
Orthopaedic Surgery Physician
Orthopaedic Surgery
Code: 207X00000X
036065978(IL)
Research & Publications (20)
Kinetics of tumor-specific T-cell response development after active immunization in patients with HER-2/neu overexpressing cancers.
PMID 17913588·Clin Immunol·2007
3-trial
Mechanisms and consequences of neuronal stretch injury in vitro differ with the model of trauma.
PMID 16503803·J Neurotrauma·2006
7-preclinical
Hormone receptor status does not affect the clinical benefit of trastuzumab therapy for patients with metastatic breast cancer.
PMID 16137436·Clin Breast Cancer·2005
8-other
Endogenous anti-HER2 antibodies block HER2 phosphorylation and signaling through extracellular signal-regulated kinase.
PMID 15695410·Cancer Res·2005
8-other
Effect of dose on immune response in patients vaccinated with an her-2/neu intracellular domain protein--based vaccine.
PMID 15143085·J Clin Oncol·2004
3-trial
Humoral epitope-spreading following immunization with a HER-2/neu peptide based vaccine in cancer patients.
PMID 15359116·J Clin Immunol·2004
3-trial
Pilot study of an HLA-A2 peptide vaccine using flt3 ligand as a systemic vaccine adjuvant.
PMID 12645861·J Clin Immunol·2003
3-trial
Immunization of cancer patients with HER-2/neu-derived peptides demonstrating high-affinity binding to multiple class II alleles.
PMID 14654536·Clin Cancer Res·2003
3-trial
Delayed type hypersensitivity response to recall antigens does not accurately reflect immune competence in advanced stage breast cancer patients.
PMID 12150448·Breast Cancer Res Treat·2002
8-other
Generation of T-cell immunity to the HER-2/neu protein after active immunization with HER-2/neu peptide-based vaccines.
PMID 12039923·J Clin Oncol·2002
3-trial
Immunization of cancer patients with a HER-2/neu, HLA-A2 peptide, p369-377, results in short-lived peptide-specific immunity.
PMID 12006513·Clin Cancer Res·2002
3-trial
Flt3 ligand as a vaccine adjuvant in association with HER-2/neu peptide-based vaccines in patients with HER-2/neu-overexpressing cancers.
PMID 11929774·Blood·2002
3-trial
Adoptive T-cell therapy for the treatment of solid tumours.
PMID 11772340·Expert Opin Biol Ther·2002
6-review
Clinical translation of peptide-based vaccine trials: the HER-2/neu model.
PMID 11642608·Crit Rev Immunol·2001
6-review
Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patients.
PMID 11181647·J Clin Invest·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1 MEDICAL CENTER DR
GALENA, IL 61036 - Phone
- (815) 777-1340
Quick Facts
- NPI
- 1760574214
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile